ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025
ProPhase Labs announced Dec. 19 it signed a non-binding letter of intent for a reverse merger with Advanced Biological Laboratories S.A., which could give ABL a 76% stake in the combined company. The deal framework includes a potential $10 million special dividend and carve-outs for certain receivables. ProPhase is also facing a Nasdaq compliance deadline and has approved a reverse stock split.
